Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Prodrugs01:30

Prodrugs

2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reductive Cyclization of <i>N</i>-Alkyl- and <i>N</i>-Aryl-<i>N</i>-(2-Nitrophenyl) Amides to 1,2-Disubstituted Benzimidazoles.

Molecules (Basel, Switzerland)·2026
Same author

Secondary metabolites from <i>Lobaria pulmonaria</i> (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis.

RSC advances·2026
Same author

1<i>H</i>-Indoles from Deoxybenzoin Schiff Bases by Deprotonation-S<sub>N</sub>Ar Cyclization.

Molecules (Basel, Switzerland)·2025
Same author

Inhibitors of the Bacterioferritin Ferredoxin Complex Dysregulate Iron Homeostasis and Kill <i>Acinetobacter baumannii</i> and Biofilm-Embedded <i>Pseudomonas aeruginosa</i> Cells.

ACS infectious diseases·2025
Same author

Thermodynamic and Kinetic Characterization of Colloidal Polymers of <i>N</i>-Isopropylacrylamide and Alkyl Acrylic Acids for Optical pH Sensing.

Molecules (Basel, Switzerland)·2025
Same author

Domino Synthesis of 1,2,5-Trisubstituted 1<i>H</i>-Indole-3-carboxylic Esters Using a [3+2] Strategy.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 5, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.7K

Recent Advances in Pyrimidine-Based Drugs.

Baskar Nammalwar1, Richard A Bunce2

  • 1Vividion Therapeutics, 5820 Nancy Ridge Drive, San Diego, CA 92121, USA.

Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
PubMed
Summary

Pyrimidines are versatile drug scaffolds impacting diverse therapeutic areas like cancer and neurological disorders. Their favorable medicinal chemistry properties offer new avenues for treating previously untreatable conditions.

Keywords:
anti-inflammatoryantibioticanticancerantifungalantiviralbuilding blockchronic paindiabetes mellitusimmunological treatmentneurological disorderspyrimidines

More Related Videos

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
08:46

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

8.7K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.0K

Related Experiment Videos

Last Updated: Jul 5, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.7K
Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
08:46

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

8.7K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.0K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Pharmacology

Background:

  • The pyrimidine core structure has been integral to drug development for over six decades.
  • Its significance spans multiple therapeutic categories, demonstrating broad applicability.

Purpose of the Study:

  • To survey recent advancements in pyrimidine-based drug discovery and therapeutics.
  • To highlight the role of pyrimidines in treating various diseases and their medicinal chemistry advantages.

Main Methods:

  • Literature review of pyrimidine-based drugs across different therapeutic areas.
  • Analysis of drug synthesis, biological targets, disease models, and pharmacological properties.

Main Results:

  • Pyrimidines are crucial in anti-infectives, anticancer, immunology, immuno-oncology, neurological disorders, chronic pain, and diabetes mellitus.
  • Demonstrated versatility as bioisosteres for phenyl and other aromatic systems, improving drug properties.
  • Synthesis, biological potency, ADME, and PK/PD of pyrimidine agents are discussed.

Conclusions:

  • Pyrimidine scaffolds offer significant potential for developing novel drug candidates.
  • Their adaptability and favorable properties present opportunities for treating previously intractable medical conditions.